↓ Skip to main content

Dove Medical Press

Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
14 Mendeley
Title
Effectiveness of Vortioxetine in Patients with Major Depressive Disorder in Real-World Clinical Practice: French Cohort Results from the Global RELIEVE Study
Published in
Neuropsychiatric Disease and Treatment, August 2022
DOI 10.2147/ndt.s374635
Pubmed ID
Authors

Mircea Polosan, Marc Rabbani, Michael Cronquist Christensen, Kenneth Simonsen, Hongye Ren

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 21%
Other 2 14%
Student > Ph. D. Student 1 7%
Unknown 8 57%
Readers by discipline Count As %
Unspecified 3 21%
Nursing and Health Professions 1 7%
Earth and Planetary Sciences 1 7%
Psychology 1 7%
Medicine and Dentistry 1 7%
Other 0 0%
Unknown 7 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2022.
All research outputs
#17,438,425
of 25,584,565 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,869
of 3,120 outputs
Outputs of similar age
#253,701
of 432,865 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#23
of 56 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,120 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,865 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 56 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.